Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2026-01-02 @ 1:30 PM
Study NCT ID:
NCT05781750
Status:
TERMINATED
Last Update Posted:
2025-12-05
First Post:
2023-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
Sponsor:
Kezar Life Sciences, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-03
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-12
First Submit QC Date:
None
Study First Post Date:
2023-03-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-07
Results First Submit QC Date:
None
Results First Post Date:
2025-12-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED